文献リスト

1) Augustin HG, Young KG, Thurston G, et al. Control of vascular morphogenesis and homeo­stasis through the angiopoietin-Tie system. Nat Rev Mol Cell Biol. 2009; 10: 165-77

2) Fukuhara S, Sako K, Noda K, et al. Tie2 is tied at the cell-cell contacts and to extracellular matrix by Angiopoietin–1. Exp Mol Med. 2009; 41: 133-9

3) Wong AL, Haroon ZA, Werner S, et al. Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues. Circ Res. 1997; 81: 567-74

4) Thurston G, Suri C, Smith K, et al. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin–1. Science. 1999; 286: 2511-4

5) Lee SW, Kim WJ, Choi YK, et al. SSeCKS regulates angiogenesis and tight junction for­mation in blood-brain barrier. Nat Med. 2003; 9: 900-6

6) Gavard J, Patel V, Gutkind JS. Angiopoietin–1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia. Dev Cell. 2008; 14: 25-36

7) Gavard J, Gutkind JS. VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE–cadherin. Nat Cell Biol. 2006; 8: 1223-34

8) Mammoto T, Parikh SM, Mammoto A, et al. Angiopoietin–1 requires p190RhoGAP to protect against vascular leakage in vivo. J Biol Chem. 2007; 282: 23910-8

9) Li X, Stankovic M, Bonder CS, et al. Basal and angiopoietin–1–mediated endothelial perme­ability is regulated by sphingosine kinase–1. Blood. 2008; 111: 3489-97

10) Fukuhara S, Sako K, Minami T, et al. Differential function of Tie2 at cell-cell contacts and cell-substratum contacts regulated by angiopoietin–1. Nat Cell Biol. 2008; 10: 513–26

11) Saharinen P, Eklund L, Miettinen J, et al. Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts. Nat Cell Biol. 2008; 10: 527-37

12) Hughes DP, Marron MB, Brindle NP. The antiinflammatory endothelial tyrosine kinase Tie2 interacts with a novel nuclear factor-kappaB inhibitor ABIN–2. Circ Res. 2003; 92: 630-6

13) Kim I, Moon SO, Park SK, et al. Angiopoietin–1 reduces VEGF-stimulated leukocyte adhesion to endothelial cells by reducing ICAM–1, VCAM–1, and E-selectin expression. Circ Res. 2001; 89: 477-9

14) Sako K, Fukuhara S, Minami T, et al. Angiopoietin–1 induces Krüppel-like factor 2 expression through a phosphoinositide 3-kinase/AKT-dependent activation of myocyte enhancer factor 2. J Biol Chem. 2009; 284: 5592-601

15) Fiedler U, Reiss Y, Scharpfenecker M, et al. Angiopoietin–2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation. Nat Med. 2006; 12: 235-9

16) Tressel SL, Kim H, Ni CW, et al. Angiopoietin–2 stimulates blood flow recovery after femoral artery occlusion by inducing inflammation and arteriogenesis. Arterioscler Thromb Vasc Biol. 2008; 28: 1989-95

17) Matsunaga T, Warltier DC, Tessmer J, et al. Expression of VEGF and angiopoietins–1 and –2 during ischemia-induced coronary angiogenesis. Am J Physiol Heart Circ Physiol. 2003; 285: H352-8

18) Visconti RP, Richardson CD, Sato TN. Orchestra­tion of angiogenesis and arteriovenous contribu­tion by angiopoietins and vascular endothelial growth factor (VEGF). Proc Natl Acad Sci U S A. 2002; 99: 8219–24

19) Oliner J, Min H, Leal J, et al. Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin–2. Cancer Cell. 2004; 6: 507–16

20) Reiss Y, Droste J, Heil M, et al. Angiopoietin–2 impairs revascularization after limb ischemia. Circ Res. 2007; 101: 88-96

21) Shyu KG, Manor O, Magner M, et al. Direct intramuscular injection of plasmid DNA encoding angiopoietin–1 but not angiopoietin–2 augments revascularization in the rabbit ischemic hindlimb. Circulation. 1998; 98: 2081-7

22) Shujia J, Haider HK, Idris NM, et al. Stable therapeutic effects of mesenchymal stem cell-based multiple gene delivery for cardiac repair. Cardiovasc Res. 2008; 77: 525-33

23) Ahmad SA, Liu W, Jung YD, et al. The effects of angiopoietin–1 and –2 on tumor growth and angiogenesis in human colon cancer. Cancer Res. 2001; 61: 1255-9

24) Hawighorst T, Skobe M, Streit M, et al. Activation of the Tie2 receptor by angiopoietin–1 enhances tumor vessel maturation and impairs squamous cell carcinoma growth. Am J Pathol. 2002; 160: 1381-92

25) Hayes AJ, Huang WQ, Yu J, et al. Expression and function of angiopoietin–1 in breast cancer. Br J Cancer. 2000; 83: 1154-60

26) Machein MR, Knedla A, Knoth R, et al. Angiopoietin–1 promotes tumor angiogenesis in a rat glioma model. Am J Pathol. 2004; 165: 1557-70

27) Stoeltzing O, Ahmad SA, Liu W, et al. Angio­poietin–1 inhibits vascular permeability, angio­genesis, and growth of hepatic colon cancer tumors. Cancer Res. 2003; 63: 3370-7

28) Kim SR, Lee KS, Park SJ, et al. Angiopoietin–1 variant, COMP-Ang1 attenuates hydrogen per­oxide-induced acute lung injury. Exp Mol Med. 2008; 40: 320-31

29) Mei SH, McCarter SD, Deng Y, et al. Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angio­poietin 1. PLoS Med. 2007; 4: e269

30) Simoes DC, Vassilakopoulos T, Toumpanakis D, et al. Angiopoietin–1 protects against airway inflammation and hyperreactivity in asthma. Am J Respir Crit Care Med. 2008; 177: 1314–21

31) Joussen AM, Poulaki V, Tsujikawa A, et al. Suppression of diabetic retinopathy with angio­poietin–1. Am J Pathol. 2002; 160: 1683-93

NPO医学中央雑誌刊行会 https://www.jamas.or.jp/ info@jamas.or.jp